Successful lung transplantation in patients with end-stage new coronary pneumonia with the longest ECMO assistance
Xinhua News Agency, Wuhan, May 9th (Reporters Li Changzheng and Liang Jianqiang) A 73-day-old patient with new coronary pneumonia assisted by extracorporeal membrane lung oxygenation (ECMO) received double lung transplantation at the Union Hospital of Huazhong University of Science and Technology after the nucleic acid turned negative. This is the patient with the longest preoperative assist time using ECMO in the world. As of now, this patient has good lung transplantation, stable vital signs, can communicate with medical staff, and is gradually recovering.
Huazhong University of Science and Technology Union Hospital held a press conference on the 9th to announce the news. The male patient was 54 years old. He developed systemic pain, fatigue, fever and other symptoms in January of this year. He was subsequently diagnosed with new coronary pneumonia. He received an intubation and started using ECMO on February 11. He was transferred to the Concord University of Huazhong University of Science and Technology on April 11. hospital.
Experts tried anti-viral, anti-infective, immune-enhancing, and plasma treatment. The patient's viral nucleic acid turned negative, but irreversible widespread pulmonary interstitial fibrosis and pulmonary failure occurred. Conventional treatment cannot sustain life, and lung transplantation is the only hope.
"One person, one policy, do our best to save the lives of every patient." Under the guidance of the expert group of the medical treatment group of the joint prevention and control mechanism of the new crown epidemic situation in the State Council, the Organ Transplant Center of the Union Hospital of Huazhong University of Science and Technology, Jiangsu Lung Transplant Center and Zhejiang University Experts from the first affiliated hospital and other medical institutions work together to continuously refine and refine the surgical plan.
On April 24, a team of transplant experts put on heavy protective equipment and worked hard for almost 6 hours to complete the operation. After the operation, the medical team is waiting for the patient 24 hours a day, and implements refined management to help the patient survive a series of difficulties such as postoperative bleeding, shock, infection, lung ischemia-reperfusion injury and rejection, thrombosis and embolism.
Earlier, on April 20, Wuhan University People's Hospital successfully performed a double lung transplant operation for a 65-year-old end-stage patient with new coronary pneumonia. At 20 o'clock on April 22, 44 hours after the operation, the medical staff successfully removed the ECMO that assisted him for 62 days. The patient was able to eat and speak on May 9.
"At all costs, looking for treatment opportunities and using unconventional means to give patients hope for life." Ma Xudong, deputy director of the Medical Quality Division of the Medical and Medical Administration of the National Health and Health Commission, said in an interview with reporters in Wuhan on the 9th that very few Patients with new coronary pneumonia will develop irreversible fibrosis of the lungs, which is life-threatening. These patients are often complicated with heart, lung, kidney and other organ dysfunction, and the condition is complicated. The National Health and Health Commission organized a multi-disciplinary team of experts to comprehensively evaluate the condition, refine the plan, allocate resources in a timely manner, and guide the postoperative fine management to ensure the smooth operation of the operation and the good recovery of patients.
Ma Xudong said: "The successful operation of these two cases is due to the party and the government upholding the people-oriented concept and saving people at all costs. It is also due to the continuous development of China's organ transplantation business in recent years, the establishment of a complete organ donation registration, Distribution and transhipment system. "